Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus

Hyperuricaemia is associated with an increased risk of gout, kidney stones and cardiovascular disease. The present post hoc analysis of pooled data from four placebo‐controlled phase III studies assessed the effect of canagliflozin, a sodium‐glucose co‐transporter 2 inhibitor, on serum uric acid lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, M. J., Trujillo, A., Vijapurkar, U., Damaraju, C. V., Meininger, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054919/
https://www.ncbi.nlm.nih.gov/pubmed/25600248
http://dx.doi.org/10.1111/dom.12439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054919/
https://www.ncbi.nlm.nih.gov/pubmed/25600248
http://dx.doi.org/10.1111/dom.12439

Ejemplares similares